Quick Answer
Larimar Therapeutics, Inc. reported Total Assets of $145.84 million for fiscal year 2025.
Larimar Therapeutics, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $145.84M | -27.2% |
| 2024 | $200.22M | +108.7% |
| 2023 | $95.94M | -24.1% |
| 2022 | $126.41M | +60.7% |
| 2021 | $78.67M | -24.9% |
| 2020 | $104.69M | +1912.8% |
| 2019 | $5.20M | -95.7% |
| 2018 | $121.76M | +15.4% |
| 2017 | $105.51M | -19.8% |
| 2016 | $131.62M | -30.4% |
| 2015 | $189.11M | +60.9% |
| 2014 | $117.52M | +208.1% |
| 2013 | $38.14M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $187.35M | -14.5% | +24.9% |
| June 30, 2025 | $149.99M | -36.8% | -11.9% |
| March 31, 2025 | $170.18M | -31.4% | -15.0% |
| December 31, 2024 | $200.22M | +108.7% | -8.6% |
| September 30, 2024 | $219.02M | +110.7% | -7.6% |
| June 30, 2024 | $237.16M | +112.3% | -4.4% |
| March 31, 2024 | $248.21M | +108.7% | +158.7% |
| December 31, 2023 | $95.94M | -24.1% | -7.7% |
- Larimar Therapeutics, Inc. showed a decrease of -27.2% in Total Assets compared to the prior fiscal year.
- Over the 2013–2025 period, Larimar Therapeutics, Inc.’s total assets has grown by 282.4% (from $38.14 million to $145.84 million).
- The most recent figure is from Larimar Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 19, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: